Suven Life Sciences Achieves 52-Week High Amid Broader Market Decline
Suven Life Sciences has reached a new 52-week high of Rs. 175, reflecting strong performance in the small-cap pharmaceutical sector. The stock has gained 33.46% over the past five days and is trading above key moving averages, despite a broader market decline. Over the past year, it has delivered a 72.86% return.
Suven Life Sciences has made headlines today as its stock price reached a new 52-week high of Rs. 175, marking a significant milestone for the small-cap pharmaceutical company. This surge represents a notable 13.71% increase during the trading session and reflects a robust performance, outperforming its sector by 10.02%. Over the past five days, Suven Life Sciences has shown impressive momentum, gaining 33.46% in returns.The stock has exhibited high volatility today, with an intraday volatility of 8.16%, indicating active trading. Additionally, Suven Life Sciences is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend in its price performance.
In the broader market context, the Sensex has experienced a sharp decline, falling by 818.59 points to 81,431.01, while small-cap stocks have shown resilience, with the BSE Small Cap index gaining 0.87%. Over the past year, Suven Life Sciences has delivered a remarkable 72.86% return, significantly outpacing the Sensex's 11.90% performance.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
